Liu, G. Y. & Sabatini, D. M. mTOR at the nexus of nutrition, growth, ageing and disease. Nat. Rev. Mol. Cell Biol. 21, 183–203 https://doi.org/10.1038/s41580-019-0199-y (2020). Article PubMed PubMed Central CAS Google Scholar Meyuhas, O. & Kahan, T. The race to decipher the top secrets of TOP mRNAs. Biochim. Biophys. Acta 1849, 801–811 https://doi.org/10.1016/j.bbagrm.2014.08.015 (2015).
The number of influenza infections could be reduced by an mRNA vaccine.Credit: Science Photo Library On 5 August, the US Food and Drug Administration (FDA) granted approval to Moderna’s mRNA-based flu vaccine, mFLUSIVA, for adults aged 50–64, and accelerated approval for adults aged 65 and older. Moderna say it will be available “in a few
